|
US4683202A
(en)
|
1985-03-28 |
1987-07-28 |
Cetus Corporation |
Process for amplifying nucleic acid sequences
|
|
US5223409A
(en)
|
1988-09-02 |
1993-06-29 |
Protein Engineering Corp. |
Directed evolution of novel binding proteins
|
|
US5530101A
(en)
|
1988-12-28 |
1996-06-25 |
Protein Design Labs, Inc. |
Humanized immunoglobulins
|
|
US5676978A
(en)
|
1989-02-14 |
1997-10-14 |
Amira, Inc. |
Methods of inhibiting undesirable cell growth using a combination of a cyclocreatine compound and a hyperplastic inhibitory agent
|
|
US5324731A
(en)
|
1989-02-14 |
1994-06-28 |
Amira, Inc. |
Method of inhibiting transformation of cells in which purine metabolic enzyme activity is elevated
|
|
US6040138A
(en)
|
1995-09-15 |
2000-03-21 |
Affymetrix, Inc. |
Expression monitoring by hybridization to high density oligonucleotide arrays
|
|
US5215882A
(en)
|
1989-11-30 |
1993-06-01 |
Ortho Diagnostic Systems, Inc. |
Method of immobilizing nucleic acid on a solid surface for use in nucleic acid hybridization assays
|
|
EP0519596B1
(en)
|
1991-05-17 |
2005-02-23 |
Merck & Co. Inc. |
A method for reducing the immunogenicity of antibody variable domains
|
|
ES2136092T3
(es)
|
1991-09-23 |
1999-11-16 |
Medical Res Council |
Procedimientos para la produccion de anticuerpos humanizados.
|
|
US5639641A
(en)
|
1992-09-09 |
1997-06-17 |
Immunogen Inc. |
Resurfacing of rodent antibodies
|
|
US5837832A
(en)
|
1993-06-25 |
1998-11-17 |
Affymetrix, Inc. |
Arrays of nucleic acid probes on biological chips
|
|
US5807522A
(en)
|
1994-06-17 |
1998-09-15 |
The Board Of Trustees Of The Leland Stanford Junior University |
Methods for fabricating microarrays of biological samples
|
|
DE69621507T2
(de)
|
1995-03-28 |
2003-01-09 |
Japan Science And Technology Corp., Kawaguchi |
Verfahren zur molekularen Indexierung von Genen unter Verwendung von Restriktionsenzymen
|
|
US5843974A
(en)
*
|
1995-06-06 |
1998-12-01 |
Eli Lilly And Company |
Methods of inhibiting melanoma using Benzothiophenes as cytotoxic agents per se
|
|
US5958342A
(en)
|
1996-05-17 |
1999-09-28 |
Incyte Pharmaceuticals, Inc. |
Jet droplet device
|
|
US6060240A
(en)
|
1996-12-13 |
2000-05-09 |
Arcaris, Inc. |
Methods for measuring relative amounts of nucleic acids in a complex mixture and retrieval of specific sequences therefrom
|
|
US6090556A
(en)
|
1997-04-07 |
2000-07-18 |
Japan Science & Technology Corporation |
Method for quantitatively determining the expression of a gene
|
|
US5994076A
(en)
|
1997-05-21 |
1999-11-30 |
Clontech Laboratories, Inc. |
Methods of assaying differential expression
|
|
CA2314397C
(en)
|
1997-12-12 |
2010-04-13 |
University Of Western Ontario |
Novel peptide, apoep1.b, compositions and uses thereof
|
|
US6004755A
(en)
|
1998-04-07 |
1999-12-21 |
Incyte Pharmaceuticals, Inc. |
Quantitative microarray hybridizaton assays
|
|
US6048695A
(en)
|
1998-05-04 |
2000-04-11 |
Baylor College Of Medicine |
Chemically modified nucleic acids and methods for coupling nucleic acids to solid support
|
|
US6087112A
(en)
|
1998-12-30 |
2000-07-11 |
Oligos Etc. Inc. |
Arrays with modified oligonucleotide and polynucleotide compositions
|
|
US6316503B1
(en)
|
1999-03-15 |
2001-11-13 |
Tularik Inc. |
LXR modulators
|
|
US8257750B2
(en)
|
1999-04-30 |
2012-09-04 |
Kibow Biotech, Inc. |
Calcium carbonate compositions for preventing or treating hyperphosphatemia
|
|
AU2001280576A1
(en)
|
2000-07-18 |
2002-01-30 |
Uab Research Foundation |
Tissue-specific self-inactivating gene therapy vector
|
|
US20030027335A1
(en)
|
2000-09-07 |
2003-02-06 |
Ruley H. Earl |
Genome engineering by cell-permeable DNA site-specific recombinases
|
|
JP2004509161A
(ja)
|
2000-09-18 |
2004-03-25 |
グラクソ グループ リミテッド |
Ｌｘｒのアゴニストとして有用な置換アミノプロポキシアリール誘導体
|
|
AU2002219718A1
(en)
|
2000-12-13 |
2002-06-24 |
Sca Hygiene Products Zeist B.V. |
Process for oxidising primary alcohols
|
|
JP2003033179A
(ja)
|
2001-07-05 |
2003-02-04 |
Asahi Kasei Corp |
可逆的遺伝子導入ベクター
|
|
EP1487776A4
(en)
*
|
2002-03-27 |
2005-05-25 |
Smithkline Beecham Corp |
ACID COMPOUNDS AND ESTERS AND METHODS OF USE THEREOF
|
|
AU2003226094A1
(en)
|
2002-03-27 |
2003-10-13 |
Smithkline Beecham Corporation |
Compounds and methods
|
|
US7247748B2
(en)
|
2002-03-27 |
2007-07-24 |
Smithkline Corporation |
Amide compounds and methods of using the same
|
|
WO2004009765A2
(en)
|
2002-07-19 |
2004-01-29 |
Althea Technologies, Inc. |
Strategies for gene expression analysis
|
|
US7135575B2
(en)
*
|
2003-03-03 |
2006-11-14 |
Array Biopharma, Inc. |
P38 inhibitors and methods of use thereof
|
|
WO2004078939A2
(en)
|
2003-03-03 |
2004-09-16 |
University Of Massachusetts |
REGULATION OF Mdm2 FUNCTION
|
|
US20050130919A1
(en)
|
2003-07-18 |
2005-06-16 |
University Of Massachusetts |
Regulatable promoters for synthesis of small hairpin RNA
|
|
WO2005039643A2
(en)
|
2003-10-20 |
2005-05-06 |
Nsgene A/S |
In vivo gene therapy of parkinson's disease
|
|
RU2006124843A
(ru)
|
2003-12-12 |
2008-01-20 |
Уайт (Us) |
Хинолины, пригодные для лечения сердечно-сосудистого заболевания
|
|
FR2865736B1
(fr)
|
2004-02-02 |
2006-07-14 |
Synt Em |
Inhibiteurs de l'angiogenese, compositions les contenant et leur utilisation pour le traitement des maladies liees a une deregulation de l'angiogenese
|
|
US20050289659A1
(en)
|
2004-05-18 |
2005-12-29 |
Jacks E T |
Cre-lox based method for conditional RNA interference
|
|
US20080255111A1
(en)
*
|
2004-07-02 |
2008-10-16 |
Sankyo Company Limited |
Tissue Factor Production Inhibitor
|
|
AU2005272043B2
(en)
|
2004-07-07 |
2010-07-29 |
Merck Sharp & Dohme Corp. |
Pyrazole amide derivatives, compositions containing such compounds and methods of use
|
|
US20060058311A1
(en)
|
2004-08-14 |
2006-03-16 |
Boehringer Ingelheim International Gmbh |
Combinations for the treatment of diseases involving cell proliferation
|
|
JP4620123B2
(ja)
|
2004-10-01 |
2011-01-26 |
エフ．ホフマン−ラ ロシュ アーゲー |
ヘキサフルオロイソプロパノール置換エーテル誘導体
|
|
JP4644714B2
(ja)
|
2004-12-22 |
2011-03-02 |
エフ．ホフマン−ラ ロシュ アーゲー |
新規なシクロヘキサン誘導体
|
|
SE0500056D0
(sv)
|
2005-01-10 |
2005-01-10 |
Astrazeneca Ab |
Therapeutic agents 4
|
|
CA2592771A1
(en)
|
2005-01-10 |
2006-07-13 |
Astrazeneca Ab |
Derivatives of isothiazol-3(2h)-one 1,1-dioxides as liver x receptor modulators
|
|
SE0500058D0
(sv)
|
2005-01-10 |
2005-01-10 |
Astrazeneca Ab |
Therapeutic agents 5
|
|
SE0500055D0
(sv)
|
2005-01-10 |
2005-01-10 |
Astrazeneca Ab |
Therapeutic agents 3
|
|
WO2006073364A1
(en)
|
2005-01-10 |
2006-07-13 |
Astrazeneca Ab |
Derivatives of isothiazol-3 (2h)-thione 1,1-dioxides as liver x receptor modulators
|
|
BRPI0607404A2
(pt)
|
2005-03-01 |
2009-09-01 |
Wyeth Corp |
compostos de cinolina e seu uso como moduladores de receptor de x hepático
|
|
US8318760B2
(en)
|
2005-03-21 |
2012-11-27 |
Merck Sharp & Dohme Corp. |
Substituted aryl and heteroaryl derivatives, compositions containing such compounds and methods of use
|
|
US8703805B2
(en)
|
2005-06-27 |
2014-04-22 |
Exelixis Patent Company Llc |
Modulators of LXR
|
|
HRP20110498T1
(hr)
|
2005-10-07 |
2011-08-31 |
Exelixis |
Azetidini kao inhibitori mek za liječenje proliferativnih bolesti
|
|
US7790745B2
(en)
|
2005-10-21 |
2010-09-07 |
Bristol-Myers Squibb Company |
Tetrahydroisoquinoline LXR Modulators
|
|
US7741317B2
(en)
|
2005-10-21 |
2010-06-22 |
Bristol-Myers Squibb Company |
LXR modulators
|
|
RU2008123388A
(ru)
|
2005-11-14 |
2009-12-27 |
Айрм Ллк (Bm) |
Соединения и композиции в качестве модуляторов lxr
|
|
WO2007081335A1
(en)
|
2006-01-12 |
2007-07-19 |
Merck & Co., Inc. |
Therapeutic compounds for treating dyslipidemic conditions
|
|
WO2007108749A1
(en)
|
2006-03-20 |
2007-09-27 |
Cepep Iii Ab |
Chimeric constructs between cancer-homing peptides and cell-penetrating peptides coupled to anticancer drugs and/or diagnostic agent/agents
|
|
US20100048944A1
(en)
*
|
2006-07-19 |
2010-02-25 |
Farhad Parhami |
Interactions of hedgehog and liver x receptor signaling pathways
|
|
TW200825054A
(en)
|
2006-10-18 |
2008-06-16 |
Wyeth Corp |
Quinoline compounds
|
|
US8324367B2
(en)
|
2006-11-03 |
2012-12-04 |
Medtronic, Inc. |
Compositions and methods for making therapies delivered by viral vectors reversible for safety and allele-specificity
|
|
ES2380499T3
(es)
|
2006-11-30 |
2012-05-14 |
Kowa Company. Ltd. |
Compuesto de Carbinol sustituido
|
|
KR20090094125A
(ko)
|
2006-12-08 |
2009-09-03 |
엑셀리시스, 인코포레이티드 |
Ｌｘｒ 및 ｆｘｒ 조절자
|
|
JP2008179562A
(ja)
|
2007-01-24 |
2008-08-07 |
Kowa Co |
Ｌｘｒアゴニスト
|
|
US8993628B2
(en)
|
2007-02-23 |
2015-03-31 |
City Of Hope |
Synthetic ligands selective for LXRβ over LXRα, identification and methods of use thereof
|
|
BRPI0811091A8
(pt)
|
2007-05-18 |
2015-09-29 |
Wyeth Corp |
Composto, composição farmacêutica, métodos para prevenir ou tratar uma doença, distúrbio ou condição, para aumentar níveis de colesterol hdl no soro em um indivíduo, para reduzir níveis de colestetol ldl no soro em um indivíduo, para aumentar o transporte invertido de colesterol em um indivíduo, e para reduzir a absorção do colesterol em um indivíduo, e, uso de um composto
|
|
EP3443976A1
(en)
|
2007-06-29 |
2019-02-20 |
Sarepta Therapeutics, Inc. |
Tissue specific peptide conjugates and methods
|
|
MX2010001742A
(es)
|
2007-08-13 |
2010-03-10 |
Hoffmann La Roche |
Nuevos derivados de piperazina-amida.
|
|
TW200922582A
(en)
|
2007-08-20 |
2009-06-01 |
Organon Nv |
N-benzyl, N'-arylcarbonylpiperazine derivatives
|
|
US8039493B2
(en)
|
2007-09-27 |
2011-10-18 |
Hoffmann-La Roche Inc. |
Biaryl sulfonamide derivatives
|
|
EP2623599B1
(en)
*
|
2007-10-04 |
2019-01-02 |
Roche Innovation Center Copenhagen A/S |
Micromirs
|
|
ES2572356T3
(es)
|
2007-11-09 |
2016-05-31 |
Peregrine Pharmaceuticals Inc |
Composiciones de anticuerpos dirigidos contra VEGF y procedimientos
|
|
US8236753B2
(en)
*
|
2007-12-10 |
2012-08-07 |
The Brigham And Women's Hospital, Inc. |
RAP variants for drug delivery and methods of use thereof
|
|
AU2008345681A1
(en)
|
2007-12-21 |
2009-07-09 |
Wyeth Llc |
Imidazo [1,2-a] pyridine compounds
|
|
US20110034526A1
(en)
|
2007-12-21 |
2011-02-10 |
Wyeth Llc |
Benzimidazole Compounds
|
|
US20100331333A1
(en)
|
2007-12-21 |
2010-12-30 |
Wyeth Llc |
Imidazo [1,2-B] Pyridazine Compounds
|
|
CN101952293A
(zh)
|
2007-12-21 |
2011-01-19 |
惠氏有限责任公司 |
吡唑并[1,5-a]嘧啶化合物
|
|
US7919509B2
(en)
|
2008-02-29 |
2011-04-05 |
Kowa Company, Ltd. |
2-oxochromene derivatives
|
|
EP2286220A2
(en)
*
|
2008-05-29 |
2011-02-23 |
Bristol-Myers Squibb Company |
Methods for predicting patient response to modulation of the co-stimulatory pathway
|
|
JP5706818B2
(ja)
*
|
2008-07-01 |
2015-04-22 |
コグノッシ， インコーポレイテッド |
ＡｐｏＥペプチドにより癌を治療する方法
|
|
KR101814408B1
(ko)
|
2008-09-26 |
2018-01-04 |
다나-파버 캔서 인스티튜트 인크. |
인간 항-ｐｄ-１, ｐｄ-ｌ１, 및 ｐｄ-ｌ2 항체 및 그의 용도
|
|
US20120156216A1
(en)
*
|
2009-03-02 |
2012-06-21 |
Youngman Oh |
Methods and Compositions for Treatment of Tumor Metastasis
|
|
KR101676704B1
(ko)
*
|
2009-05-28 |
2016-11-16 |
엑셀리시스 페이턴트 컴퍼니 엘엘씨 |
Ｌｘｒ 조절자
|
|
WO2011115892A1
(en)
*
|
2010-03-15 |
2011-09-22 |
Griffin Patrick R |
Modulators of the retinoic acid receptor-related orphan receptors
|
|
WO2011130426A2
(en)
*
|
2010-04-13 |
2011-10-20 |
New York University |
Compositions and methods for treatment of melanoma
|
|
EP2584045A4
(en)
|
2010-06-16 |
2013-12-04 |
Nat Univ Corp Hamamatsu |
METHOD FOR DETECTING COLORECTAL CANCER
|
|
EP2474617A1
(en)
*
|
2011-01-11 |
2012-07-11 |
InteRNA Technologies BV |
Mir for treating neo-angiogenesis
|
|
US20130004481A1
(en)
*
|
2011-01-12 |
2013-01-03 |
Boehringer Ingelheim International Gmbh |
Anticancer therapy
|
|
TW201242953A
(en)
|
2011-03-25 |
2012-11-01 |
Bristol Myers Squibb Co |
Imidazole prodrug LXR modulators
|
|
WO2013043569A1
(en)
*
|
2011-09-20 |
2013-03-28 |
Vical Incorporated |
Synergistic anti-tumor efficacy using alloantigen combination immunotherapy
|
|
EP3626309B1
(en)
*
|
2012-08-13 |
2023-03-08 |
The Rockefeller University |
Lxrbeta agonist for the treatment of cancer
|